LOS ANGELES, March 13 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN) has received its second Frost & Sullivan Technology Award in the past three years. On March 12, 2008, at the Frost & Sullivan Awards Banquet, Signalife was awarded the Frost & Sullivan Technology Innovation Award for North American Patient Monitoring. Signalife's Chief Executive Officer, Dr. Lowell Harmison, and its inventor and Chief Scientist, Dr. Budimir Drakulic, were present to accept the award.
Signalife, Inc. is in a rare and prestigious group of companies, as a device-maker that has won the award from Frost & Sullivan two times in the past three years.
In the words of Frost & Sullivan, the Technology Award "is presented to Signalife in recognition of its superior leadership and vision in patient monitoring with its Fidelity heart monitoring systems. Signalife's unique technology provides unprecedented signal clarity in the highly sought-after real-time, wireless cardiac monitoring arena."
Frost & Sullivan continues: "Signalife strived to provide one of the most trustworthy and reliable wireless monitoring product out there, and they accomplished this by creating a technology that significantly reduced and effectively eliminated artifact noise before the ECG signal is amplified. This results in no need to filter the signal after it has been amplified preserving the entire ECG's data. Using this as the basis of all their technology, Signalife has been able to set themselves apart from other cardiac monitors. The Fidelity 100 is the first of their products, and is comprised of a wireless, real-time 12 lead ECG system ... "
Frost & Sullivan concludes: "While the Fidelity 100 product alone makes
a case for product innovation, what really puts Signalife over the top is
its other two products at end stage development, [including the Fidelity
200, which] is taking cardiac event monitoring to a place the industry has
never been before, the over the counter,
|SOURCE Signalife, Inc.|
Copyright©2008 PR Newswire.
All rights reserved